MarketFusobacteriota
Company Profile

Fusobacteriota

Fusobacteriota are obligately anaerobic non-sporeforming Gram-negative bacilli. Since the first reports in the late nineteenth century, various names have been applied to these organisms, sometimes with the same name being applied to different species. More recently, not only have there been changes to the nomenclature, but also attempts to differentiate between species which are believed to be either pathogenic or commensal or both. Because of their asaccharolytic nature, and a general paucity of positive results in routine biochemical tests, laboratory identification of the Fusobacteriota has been difficult. However, the application of novel molecular biological techniques to taxonomy has established a number of new species, together with the subspeciation of Fusobacterium necrophorum and F. nucleatum, and provided new methods for identification. The involvement of Fusobacteriota in a wide spectrum of human infections causing tissue necrosis and septicaemia has long been recognised, and, more recently, their importance in intra-amniotic infections, premature labour and tropical ulcers has been reported.

Phylogeny
The currently accepted taxonomy is based on the List of Prokaryotic names with Standing in Nomenclature (LSPN) and National Center for Biotechnology Information (NCBI). ==Role in human disease==
Role in human disease
New evidence is emerging that this bacterium may cause or be related to human colon cancer. In 2011 investigators reported the presence of Fusobacteriota in colon cancer tissue (Genome Res 2012; 22:292) and a new multicenter study provides evidence that some cases-particularly right-sided might be caused by infection by Fusobacteriota. ==References==
tickerdossier.comtickerdossier.substack.com